Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010

Emerging Infectious Diseases

Volumn 17, Issue 10, 2011, Pages 1807-1815

  Calatayud, Laurence ^a   Lackenby, Angie ^a   Reynolds, Arlene ^b   McMenamin, Jim ^b   Phin, Nick F ^a   Zambon, Maria C ^a   Pebody, Richard ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BRONCHITIS; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; INFECTION RISK; KIDNEY DISEASE; LIVER DISEASE; MALE; NEUROLOGIC DISEASE; OTITIS; PNEUMONIA; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; RISK FACTOR; SCHOOL CHILD; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; ENGLAND; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MUTATION; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; RISK FACTORS; SCOTLAND; YOUNG ADULT;

EID: 84930476719     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1710.110117     Document Type: Article

References (39)

1. McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003;47:2264-72. doi:10.1128/ AAC.47.7.2264-2272.2003
2. National Institute for Health and Clinical Excellence. Influenza- zanamivir, amantadine and oseltamivir (review). Amantadine, oseltamivir, and zanamivir for the treatment of influenza (review of existing guidance no. 58). NICE; Feb 2009 [cited 2011 Jun 12]. http://guidance.nice.org.uk/TA168
3. Department of Health. Swine flu pandemic: from containment to treatment. Guidance for the NHS, 2 July 2009. The Organization; 2009 [cited 2011 Jun 12]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_102021.pdf
4. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52:3284-92. doi:10.1128/AAC.00555-08
5. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004;364:759-65. doi:10.1016/S0140-6736(04)16934-1
6. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis. 2006;193:760-4. doi:10.1086/500465
7. Mishin VP, Hayden FG, Gubareva LV. Susceptibilities of antiviral- resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother. 2005;49:4515-20. doi:10.1128/ AAC.49.11.4515-4520.2005
8. Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis. 2004;190:1627-30. doi:10.1086/424572
9. Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, et al. Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill. 2009;14:pii:19412.
10. Centers for Disease Control and Prevention. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:433-5.
11. World Health Organization. Viruses resistant to oseltamivir (Tamiflu) identified. Pandemic (H1N1) 2009 briefing note 1. The Organization; 2009 [cited 2011 Jan 20]. http://www.who.int/csr/disease/swineflu/notes/h1n1_antiviral_resistance_20090708/en
12. World Health Organization. Pandemic (H1N1) 2009-update 98. Weekly virological surveillance update. Geneva: The Organization; 2010 [cited 2011 Jan 11]. http://www.who.int/csr/disease/swineflu/laboratory30_04_2010/en
13. Moore C, Galiano M, Lackenby A, Abdelrahman T, Barnes R, Evans MR, et al. Evidence of person-to-person transmission of oseltamivirresistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J Infect Dis. 2011;203:18-24. doi:10.1093/infdis/jiq007
14. Centers for Disease Control and Prevention. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:969-72.
15. Mai LQ, Wertheim HF, Duong TN, van Doorn HR, Hein NT, Horby P, et al. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med. 2010;362:86-7. doi:10.1056/NEJMc0910448
16. World Health Organization. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009.Wkly Epidemiol Rec. 2009;84:453-9.
17. Leung TW, Tai AL, Cheng PK, Kong MS, Lim W. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. J Clin Virol. 2009;46:29:8-9. doi:10.1016/j.jcv.2009.08.004
18. Centers for Disease Control and Prevention. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:893-6.
19. Esposito S, Molteni CG, Colombo C, Daleno C, Daccò V, Lackenby A, et al. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. J Clin Virol. 2010;48:62-5. doi:10.1016/j.jcv.2010.02.019
20. Lackenby A, Democratis J, Siqueira MM, Zambon MC. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir Ther. 2008;13:809-20.
21. Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG, Sachedina N, et al. Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol Infect. 2010;26:1-10. doi:10.1017/ S0950268810002657
22. Health Protection Agency; Health Protection Scotland; National Public Health Service for Wales; HPA Northern Ireland swine influenza investigation teams. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Euro Surveill. 2009;14:pii:19232.
23. Chen H, Cheung CL, Tai H, Zhao P, Chan JF, Cheng VC, et al. Oseltamivir- resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis. 2009;15:1970-2. doi:10.3201/ eid1512.091057
24. World Health Organization. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec. 2009;85:37-40.
25. McLean E, Pebody RG, Campbell C, Chamberland M, Hawkins C, Nguyen-Van-Tam JS, et al. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect. 2010;138:1531-41. doi:10.1017/ S0950268810001366
26. Pebody RG, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect. 2008;136:360-9. doi:10.1017/S0950268807008436
27. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361:1935-44. doi:10.1056/NEJMoa0906695
28. Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009. United States. Emerg Infect Dis. 2011;17:255-7.
29. Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, et al. M. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010;16:1068-75. doi:10.3201/eid1607.091691
30. Hurt AC, Deng YM, Ernest J, Caldwell N, Leang L, Iannello P, et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill. 2011;16:pii:19770.
31. Ison MG. Epidemiology, prevention, and management of influenza in patients with hematologic malignancy. Infect Disord Drug Targets. 2011;11:34-9.
32. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006;85:278-87. doi:10.1097/01.md.0000232560.22098.4e
33. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R.; California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896-902. doi:10.1001/ jama.2009.1583
34. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, et al. Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice. Science. 2009;325:484-7.
35. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ. 2009;339:b5213. doi:10.1136/bmj.b5213
36. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925-34. doi:10.1056/NEJMoa0908481
37. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ. 2010;182:257-64. doi:10.1503/cmaj.091884
38. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, et al.; ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004;30:51-61. doi:10.1007/s00134-003-2136-x
39. Harvala H, Gunson R, Simmonds P, Hardie A, Bennett S, Scott F, et al. The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill. 2010;15:pii:19536.